Kelly Chin, M.D.
When pulmonologist Kelly Chin, M.D., started treating patients with pulmonary hypertension, it was a newly treatable disease – only six years before, there were no effective treatment options for most people with the disease.
We offer access to the best treatments for pulmonary hypertension."
Since then, she's witnessed multiple advances in treatment options for patients who suffer from this often fatal disease. The opportunity for her patients to live a better life motivates her.
"After we've started them on therapy, we can see patients get better and really respond in a positive way,” she says. “It's very rewarding as a physician to impact someone's life in that way."
As Director of UT Southwestern Medical Center's Pulmonary Hypertension Program, Dr. Chin has also seen the Program grow quickly. It now ranks among the largest centers in the country, providing access to state-of-the-art treatments.
In addition to clinical care, Dr. Chin spends time researching causes and new treatments for pulmonary hypertension. While experts have identified some risk factors for the disease such as medication exposures and certain genes, there is a need to learn more. Dr. Chin is exploring other potential causes, such as a possible connection between stimulant use and pulmonary hypertension.
Dr. Chin loves seeing the impact new therapies can have on her patients. A pulmonary hypertension diagnosis no longer means a patient is going to die within a few years, she says.
"While it’s still a serious condition, many people improve and feel a lot better,” Dr. Chin notes. “It's certainly treatable. Patients can achieve a significant improvement in quality of life with medication. "